Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 16 August

Jessica Amir
August 16, 2021

Weekly Wrap 13 August

Jessica Amir
August 13, 2021

Morning Bell 13 August

Sophia Mavridis
August 13, 2021

Morning Bell 12 August

Paulina Peters
August 12, 2021

Morning Bell 11 August

Jessica Amir
August 11, 2021

Morning Bell 10 August

Jessica Amir
August 10, 2021

Morning Bell 9 August

Jessica Amir
August 9, 2021

Weekly Wrap 6 August

Jessica Amir
August 6, 2021

Morning Bell 6 August

Paulina Peters
August 6, 2021

Morning Bell 5 August

Sophia Mavridis
August 5, 2021

Morning Bell 4 August

Jessica Amir
August 4, 2021